NASDAQ:LYEL | EBITDA Margin | Lyell Immunopharma, Inc.

Complete source-backed ebitda margin history.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-03-31-2096450.00%
2025-12-31-2087450.00%
2025-03-31-770371.43%
2024-12-31-1782918.18%
2024-03-31-1685033.33%
2023-12-31-418853.85%
2023-03-31-88506.15%
2022-12-31-20.14%
2022-03-31-11643.58%
2021-12-31-1522.79%
2021-03-31-2184.54%
2020-12-31-1646.71%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-31-716291.67%
2024-12-31-555940.98%
2023-12-31-174429.23%
2022-12-31-199.61%
2021-12-31-1888.75%
2020-12-31-2677.19%
2019-12-31-15347.49%